Understanding COPD: Symptoms, GOLD Stages, Spirometry & Treatment Options

Welcome to this podcast episode on Chronic Obstructive Pulmonary Disease (COPD). COPD is a progressive lung condition characterized by persistent airflow limitation, primarily encompassing chronic bronchitis and pulmonary emphysema. In this episode, we explore the underlying biological mechanisms, core symptoms, diagnostic spirometry, and evidence-based therapeutic management strategies. 🎙️️ Key Topics Covered in This Podcast Episode: What is COPD? Definition of persistent airflow obstruction, distinguishing chronic bronchitis (productive cough) from lung emphysema (alveolar destruction), and its global impact as the third leading cause of death worldwide. Causes & Risk Factors: Why tobacco smoke accounts for over 70% of cases in high-income countries, alongside air pollution, occupational dusts, and genetic factors like Alpha-1 antitrypsin deficiency. Symptoms & Clinical Signs: Core manifestations including exertional dyspnea (shortness of breath), chronic cough, phlegm production, and wheezing. Diagnosis & GOLD Staging: How post-bronchodilator spirometry (FEV₁/FVC weniger als 0.70) confirms diagnosis, alongside GOLD severity grades (1–4) and clinical risk groups (A, B, E).. Therapy & Management: Non-Pharmacological: Smoking cessation as the single most critical intervention, pulmonary rehabilitation, exercise, and routine vaccinations (influenza, pneumococcal). Pharmacological: Inhaled bronchodilators (LABA, LAMA), inhaled corticosteroids (ICS) for exacerbation-prone patients, and emergency care during acute exacerbations.